HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Justyna Dzietczenia Selected Research

Proteins (Proteins, Gene)

7/2012High expression of hematopoietic cell specific Lyn substrate-1 (HS1) predicts poor survival of B-cell chronic lymphocytic leukemia patients.
12/2011Expression of cyclin A and bone morphogenetic protein receptors and response to induction therapy in patients with acute leukemias.
9/2010Expression of complement regulatory proteins: CD46, CD55, and CD59 and response to rituximab in patients with CD20+ non-Hodgkin's lymphoma.
12/2008Asymmetric dimethylarginine in hematological malignancies: a preliminary study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Justyna Dzietczenia Research Topics

Disease

5Lymphoma (Lymphomas)
10/2013 - 09/2010
4B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
03/2013 - 12/2010
3Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2013 - 09/2010
2Neoplasms (Cancer)
10/2014 - 01/2013
2Disease Progression
10/2013 - 07/2012
2Leukemia
12/2011 - 08/2011
2Hematologic Neoplasms (Hematological Malignancy)
12/2011 - 12/2008
1Heart Diseases (Heart Disease)
10/2013
1acquired Thrombotic thrombocytopenic purpura
05/2013
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2013
1Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
01/2013
1Burkitt Lymphoma (Burkitt's Lymphoma)
01/2013
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2013
1Disease Susceptibility (Diathesis)
01/2013
1Carcinoma (Carcinomatosis)
12/2011

Drug/Important Bio-Agent (IBA)

4Proteins (Proteins, Gene)FDA Link
07/2012 - 12/2008
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2013 - 01/2013
2Cytarabine (Cytosar-U)FDA LinkGeneric
01/2013 - 01/2013
2Rituximab (Mabthera)FDA Link
08/2011 - 09/2010
1Eph Family Receptors (Eph Receptors)IBA
10/2014
1thiamine triphosphorate (TTP)IBA
05/2013
1SiliconesIBA
05/2013
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
03/2013
1Bendamustine HydrochlorideFDA Link
01/2013
1Cyclin AIBA
12/2011
1Bone Morphogenetic Protein ReceptorsIBA
12/2011
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
08/2011
1CladribineFDA LinkGeneric
08/2011
1Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA
12/2010
1Monoclonal AntibodiesIBA
09/2010
1Complement System Proteins (Complement)IBA
09/2010
1Arginine (L-Arginine)FDA Link
12/2008
1symmetric dimethylarginineIBA
12/2008
1N,N-dimethylarginine (asymmetric dimethylarginine)IBA
12/2008
1Nitric Oxide (Nitrogen Monoxide)FDA Link
12/2008
1dimethylargininaseIBA
12/2008

Therapy/Procedure

2Therapeutics
01/2013 - 12/2011
1VAP-cyclo protocol
10/2013
1Drug Therapy (Chemotherapy)
10/2013
1Breast Implants (Breast Implant)
05/2013